Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore effective wise investment strategies that can help you achieve long-term gains. Learn how to grow your wealth sustainably.
27,808 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Barstool founder Dave Portnoy tells Fox Business he will hold Bitcoin to zero after buying near $100,000, underscorin...
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
A high-profile operation in Mexico ends with the death of a cartel leader, prompting a shelter-in-place advisory for ...
The FAA has halted all JetBlue flights at the airline’s request, triggering widespread travel disruption and a swift ...
On day 43 of the partial government shutdown, ICE officers begin assisting TSA at key airports to shorten security li...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...
Silicon Valley is fueling a defense tech surge, reshaping the investment landscape. This piece identifies five stocks...
Oil sits near $90 per barrel on June 12, 2026, with Brent guiding the market. Traders weigh supply discipline, demand...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
A health change after 65 can trap retirees who move from Medicare Advantage to Original Medicare with Medigap, due to...
Whale purchases surge, a technical buy signal reappears, and exchange balances retreat as XRP eyes a potential breako...